Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07088250 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Statins for Treatment of Primary Intracerebral Hemorrhage

Study acronym: STOP ICH
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 28, 2025 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting within 3 to 24 hours of symptom onset.
Trial Details
NCT Number NCT07088250
Lead Sponsor The Second Hospital of Anhui Medical University
Conditions
(from sponsor)		 Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage, Intracerebral Haemorrhage
Related terms Cerebral Hemorrhage, Cerebrovascular Disorders, Intracranial Hemorrhages
Enrollment 264 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov